JP2023544211A5 - - Google Patents
Info
- Publication number
- JP2023544211A5 JP2023544211A5 JP2023521536A JP2023521536A JP2023544211A5 JP 2023544211 A5 JP2023544211 A5 JP 2023544211A5 JP 2023521536 A JP2023521536 A JP 2023521536A JP 2023521536 A JP2023521536 A JP 2023521536A JP 2023544211 A5 JP2023544211 A5 JP 2023544211A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063089782P | 2020-10-09 | 2020-10-09 | |
| US63/089,782 | 2020-10-09 | ||
| US202163197236P | 2021-06-04 | 2021-06-04 | |
| US63/197,236 | 2021-06-04 | ||
| US202163220929P | 2021-07-12 | 2021-07-12 | |
| US63/220,929 | 2021-07-12 | ||
| PCT/CA2021/051426 WO2022073138A1 (en) | 2020-10-09 | 2021-10-08 | Polypeptides targeting sars-cov-2 and related compositions and methods |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023544211A JP2023544211A (ja) | 2023-10-20 |
| JPWO2022073138A5 JPWO2022073138A5 (https=) | 2024-10-17 |
| JP2023544211A5 true JP2023544211A5 (https=) | 2024-10-17 |
Family
ID=81126329
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023521536A Pending JP2023544211A (ja) | 2020-10-09 | 2021-10-08 | Ｓａｒｓ－ｃｏｖ－２を標的とするポリペプチドならびに関連する組成物および方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250263469A1 (https=) |
| EP (1) | EP4225804A4 (https=) |
| JP (1) | JP2023544211A (https=) |
| KR (1) | KR20230083316A (https=) |
| AU (1) | AU2021356355A1 (https=) |
| BR (1) | BR112023006497A2 (https=) |
| CA (1) | CA3197642A1 (https=) |
| MX (1) | MX2023004023A (https=) |
| WO (1) | WO2022073138A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2022212978A1 (en) * | 2021-01-28 | 2023-08-31 | The Hospital For Sick Children | Multabody constructs, compositions, and methods |
| KR20240032875A (ko) * | 2021-07-12 | 2024-03-12 | 더 호스피탈 포 식 칠드런 | 최적화된 멀타바디 작제물, 조성물 및 방법 |
| KR102946895B1 (ko) | 2022-10-21 | 2026-04-02 | 충남대학교산학협력단 | SARS-CoV-2 S1 유래 단백질 및 항체 Fc 영역 단백질을 표면에 동시에 디스플레이하는 페리틴 단백질 구조체 및 이의 코로나바이러스 SARS-CoV-2에 대한 백신 용도 |
| JP2025536337A (ja) * | 2022-10-21 | 2025-11-05 | ザ・ホスピタル・フォー・シック・チルドレン | サルベコウイルスを標的とするマルタボディ構築物、組成物および方法 |
| WO2025231346A1 (en) * | 2024-05-03 | 2025-11-06 | The Wistar Institute Of Anatomy And Biology | Anti-interferon-alpha and anti-interferon-beta antibodies, and methods of use thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2780221A1 (en) * | 2009-11-04 | 2011-05-12 | Fabrus Llc | Methods for affinity maturation-based antibody optimization |
| BR112015002091A2 (pt) * | 2012-08-02 | 2017-12-12 | Hoffmann La Roche | método para a produção de um polipeptídeo, polipeptídeo, uso de um polipeptídeo e composição |
| WO2015109212A1 (en) * | 2014-01-17 | 2015-07-23 | Pfizer Inc. | Anti-il-2 antibodies and compositions and uses thereof |
| RS59340B1 (sr) * | 2014-11-06 | 2019-10-31 | Hoffmann La Roche | Varijante fc regiona sa modifikovanim vezivanjem za fcrn i metode upotrebe |
| WO2017196847A1 (en) * | 2016-05-10 | 2017-11-16 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Variable new antigen receptor (vnar) antibodies and antibody conjugates targeting tumor and viral antigens |
| SG11201900500TA (en) * | 2016-07-22 | 2019-02-27 | Dana Farber Cancer Inst Inc | Glucocorticoid-induced tumor necrosis factor receptor (gitr) antibodies and methods of use thereof |
| WO2019023811A1 (en) * | 2017-08-04 | 2019-02-07 | The Hospital For Sick Children | NANOPARTICLE PLATFORM FOR ANTIBODY AND VACCINE DELIVERY |
| CR20220552A (es) * | 2020-04-02 | 2023-01-17 | Regeneron Pharma | Anticuerpos contra glicoproteína de espícula anti-sars-cov-2 y fragmentos de unión al antígeno |
| CN111592595B (zh) * | 2020-04-27 | 2021-02-19 | 南京医科大学 | 抗新型冠状病毒SARS-Cov-2的中和性抗体及其应用 |
-
2021
- 2021-10-08 MX MX2023004023A patent/MX2023004023A/es unknown
- 2021-10-08 WO PCT/CA2021/051426 patent/WO2022073138A1/en not_active Ceased
- 2021-10-08 US US18/030,944 patent/US20250263469A1/en active Pending
- 2021-10-08 KR KR1020237015177A patent/KR20230083316A/ko active Pending
- 2021-10-08 BR BR112023006497A patent/BR112023006497A2/pt unknown
- 2021-10-08 AU AU2021356355A patent/AU2021356355A1/en active Pending
- 2021-10-08 EP EP21876827.3A patent/EP4225804A4/en active Pending
- 2021-10-08 CA CA3197642A patent/CA3197642A1/en active Pending
- 2021-10-08 JP JP2023521536A patent/JP2023544211A/ja active Pending